1. Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacy
   Michael I. Koukourakis et al, 2019, International Journal of Radiation Biology CrossRef
2. Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer
   Wenxian Wang et al, 2020, Frontiers in Oncology CrossRef
3. A good preoperative immune prognostic index is predictive of better long-term outcomes after laparoscopic gastrectomy compared with open gastrectomy for stage II gastric cancer in elderly patients
   Guo-Sheng Lin et al, 2022, Surgical Endoscopy CrossRef
4. Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer
   Mariona Riudavets et al, 2024, Clinical Lung Cancer CrossRef
5. Pretreatment lactate dehydrogenase may predict outcome of advanced non small‐cell lung cancer patients treated with immune checkpoint inhibitors: A meta‐analysis
   Zhibo Zhang et al, 2019, Cancer Medicine CrossRef
6. Impact of sequential therapy with osimertinib on the overall survival in patients with EGFR-mutant non-small cell lung cancer
   Minehiko Inomata et al, 2022, The Egyptian Journal of Bronchology CrossRef
7. Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC
   Martin P. Barr et al, 2022, Diagnostics CrossRef
8. Prognostic value of Thyroid Transcription Factor-1 expression in lung adenocarcinoma in patients treated with anti PD-1/PD-L1
   Loïck Galland et al, 2021, OncoImmunology CrossRef
9. The usefulness of lactate dehydrogenase measurements in current oncological practice
   Agata Forkasiewicz et al, 2020, Cellular & Molecular Biology Letters CrossRef
10. Systemic Inflammatory Markers of Survival in Epidermal Growth Factor–Mutated Non–Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis
    Sze Wah Samuel Chan et al, 2021, Clinical Lung Cancer CrossRef
11. Prognostic Significance of SUVmax Combined With Lactate Dehydrogenase in Advanced Lung Cancer Patients Treated With Immune Checkpoint Inhibitor Plus Chemotherapy: A Retrospective Study
    Linping Ke et al, 2021, Frontiers in Oncology CrossRef
12. Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
    Wonyoung Park et al, 2024, International Journal of Molecular Sciences CrossRef
13. Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma
    Longqing Li et al, 2022, Frontiers in Immunology CrossRef